Form 4: Intuitive Surgical Director Executes Stock Option and Sells Shares

Sentiment:

SEC Form 4 Filing


Intuitive Surgical director Amal M. Johnson exercised stock options and sold shares on January 28, 2025, according to a recent SEC filing.

Summary

  • On January 28, 2025, Amal M. Johnson, a director at Intuitive Surgical Inc., exercised non-qualified stock options to acquire 4,635 shares of common stock at a price of $90.4944 per share.
  • Following the exercise of the options, the director sold 4,635 shares of common stock at a price of $566.6 per share.
  • After these transactions, the director directly owns 12,275 shares of Intuitive Surgical stock.

Sentiment

Score: 5

Explanation: The document reflects a routine insider transaction. It is neither particularly positive nor negative for the company's outlook.

Positives

  • The director's stock option exercise indicates a belief in the company's long-term value.
  • The sale of shares at a significantly higher price than the exercise price demonstrates a potential profit for the director.

Negatives

  • The sale of shares by a director could be perceived negatively by some investors, although it was part of a pre-arranged trading plan.

Risks

  • The sale of shares by a director, even under a pre-arranged plan, could potentially create short-term volatility in the stock price.
  • The market may interpret the sale as a lack of confidence in the company's future performance, although this is not necessarily the case.

Industry Context

This filing is a routine disclosure of insider transactions and is common for publicly traded companies. It does not indicate any specific industry trend or competitive activity.

Comparison to Industry Standards

  • Insider trading activity is a common occurrence in publicly listed companies, and the reporting of these transactions is mandated by the SEC.
  • The use of 10b5-1 trading plans is a standard practice for corporate insiders to avoid accusations of trading on non-public information.
  • The price difference between the exercise price and the sale price is typical for stock options that have vested over time.

Stakeholder Impact

  • The transaction may have a minor impact on shareholder sentiment, but it is unlikely to have a significant effect on the company's operations or financial health.
  • The sale of shares by a director could be perceived negatively by some investors, although it was part of a pre-arranged trading plan.

Key Dates

DateDescription
01/28/2025Date of stock option exercise and sale of shares by director Amal M. Johnson.
04/20/2027Expiration date of the non-statutory stock option.
05/02/2025Expiration date of the Trading Plan.

Keywords

Intuitive Surgical, ISRG, stock options, insider trading, SEC Form 4, Amal M. Johnson, stock sale, Rule 10b5-1, director

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.